Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1,2-Distearoyl-rac-glycerol is a synthetic lipid compound that consists of glycerol esterified with two stearoyl chains. It is a racemic mixture, meaning it contains both the R and S enantiomers of the compound. This lipid has unique properties that make it useful in various applications, particularly in the field of biochemistry and enzymatic assays.

51063-97-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 51063-97-9 Structure
  • Basic information

    1. Product Name: 1,2-DISTEAROYL-RAC-GLYCEROL
    2. Synonyms: DL-ALPHA,BETA-DISTEARIN;DISTEARIN;DISTEARYOYLGLYCEROL;GLYCERYL DISTEARATE;GLYCEROL DISTEARATE;1,2-DISTEAROYL-RAC-GLYCEROL;1,2-DISTEARIN;1,2-DIOCTADECANOYL-RAC-GLYCEROL
    3. CAS NO:51063-97-9
    4. Molecular Formula: C39H76O5
    5. Molecular Weight: 625.02
    6. EINECS: 256-941-4
    7. Product Categories: N/A
    8. Mol File: 51063-97-9.mol
  • Chemical Properties

    1. Melting Point: 72-74 °C
    2. Boiling Point: 662.3 °C at 760 mmHg
    3. Flash Point: 181.8 °C
    4. Appearance: /
    5. Density: 0.923 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: −20°C
    8. Solubility: N/A
    9. PKA: 13.69±0.10(Predicted)
    10. BRN: 1730305
    11. CAS DataBase Reference: 1,2-DISTEAROYL-RAC-GLYCEROL(CAS DataBase Reference)
    12. NIST Chemistry Reference: 1,2-DISTEAROYL-RAC-GLYCEROL(51063-97-9)
    13. EPA Substance Registry System: 1,2-DISTEAROYL-RAC-GLYCEROL(51063-97-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: 22-24/25
    4. WGK Germany: 1
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 51063-97-9(Hazardous Substances Data)

51063-97-9 Usage

Uses

Used in Biochemical Research:
1,2-Distearoyl-rac-glycerol is used as a substrate in the in vitro assay for monoacylglycerol transferase (MGAT) and diacylglycerol acyltransferase (DGAT) activity. These enzymes play crucial roles in lipid metabolism, and studying their activity can provide valuable insights into the regulation of lipid synthesis and its implications in various physiological and pathological processes.
In the context of MGAT, 1,2-Distearoyl-rac-glycerol serves as a donor molecule for the transfer of the stearoyl group to another lipid molecule, allowing researchers to assess the efficiency and specificity of the enzyme. Similarly, for DGAT, this compound acts as a substrate for the synthesis of triglycerides, an essential step in lipid storage and energy metabolism.
Overall, 1,2-Distearoyl-rac-glycerol is a valuable tool in biochemical research, enabling scientists to investigate the function and regulation of key enzymes involved in lipid metabolism. This knowledge can contribute to a better understanding of lipid-related diseases and the development of potential therapeutic strategies.

Check Digit Verification of cas no

The CAS Registry Mumber 51063-97-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,0,6 and 3 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 51063-97:
(7*5)+(6*1)+(5*0)+(4*6)+(3*3)+(2*9)+(1*7)=99
99 % 10 = 9
So 51063-97-9 is a valid CAS Registry Number.
InChI:InChI=1/C39H76O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(41)43-36-37(35-40)44-39(42)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h37,40H,3-36H2,1-2H3

51063-97-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (D8519)  1,2-Distearoyl-rac-glycerol  ≥99%

  • 51063-97-9

  • D8519-10MG

  • 813.15CNY

  • Detail
  • Sigma

  • (D8519)  1,2-Distearoyl-rac-glycerol  ≥99%

  • 51063-97-9

  • D8519-100MG

  • 4,057.56CNY

  • Detail

51063-97-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,2-DISTEAROYL-RAC-GLYCEROL

1.2 Other means of identification

Product number -
Other names 1,2-Distearoyl-rac-glycerol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51063-97-9 SDS

51063-97-9Relevant articles and documents

Synthesis of acylglycerol derivatives by mechanochemistry

Ardila-Fierro, Karen J.,Pich, Andrij,Spehr, Marc,Hernández, José G.,Bolm, Carsten

supporting information, p. 811 - 817 (2019/04/17)

In recent times, many biologically relevant building blocks such as amino acids, peptides, saccharides, nucleotides and nucleosides, etc. have been prepared by mechanochemical synthesis. However, mechanosynthesis of lipids by ball milling techniques has remained essentially unexplored. In this work, a multistep synthetic route to access mono- and diacylglycerol derivatives by mechanochemistry has been realized, including the synthesis of diacylglycerol-coumarin conjugates.

Synthesis process of novel compound phosphatidyl 3-hydroxypropionitrile

-

Paragraph 0010, (2018/09/21)

The invention relates to a synthesis process of a novel compound phosphatidyl 3-hydroxypropionitrile. The synthesis process comprises the following steps: using acetone glycerol as a starting material; protecting exposed hydroxyl with benzyl; removing a ketal protecting group to obtain two exposed hydroxyls; then, esterifying with stearic acid; removing benzyl protection to obtain the exposed hydroxyl; reacting with a chlorophosphine compound to obtain a phosphine oxide compound; oxidizing to obtain phosphine oxide; and removing one molecular propyl nitrile to obtain a final product phosphatidyl 3-hydroxypropionitrile.

Lipidomics characterization of biosynthetic and remodeling pathways of cardiolipins in genetically and nutritionally manipulated yeast cells

Tyurina, Yulia Y.,Lou, Wenjia,Qu, Feng,Tyurin, Vladimir A.,Mohammadyani, Dariush,Liu, Jenney,Huttemann, Maik,Frasso, Michael A.,Wip, Peter,Bayir, Hulya,Greenberg, MiriaM. L.,Kagan, Valerian E.

, p. 265 - 281 (2018/01/02)

Cardioipins (CLs) are unique tetra-acylated phospholipids of mitochondria and define the bioenergetics and regulatory functions of these organelles. An unresolved paradox is the high uniformity of CL molecular species (tetra-linoleoyl-CL) in the heart, liver, and skeletal muscles-in contrast to their high diversification in the brain. Here, we combined liquid chromatography-mass-spectrometry-based phospholipidomics with genetic and nutritional manipulations to explore CLs' biosynthetic vs postsynthetic remodeling processes in S. cerevisiae yeast cells. By applying the differential phospholipidomics analysis, we evaluated the contribution of Cld1 (CL-specific phospholipase A) and Taz1 (acyl-transferase) as the major regulatory mechanisms of the remodeling process. We further established that nutritional "pressure" by high levels of free fatty acids triggered a massive synthesis of homoacylated molecular species in all classes of phospholipids, resulting in the preponderance of the respective homoacylated CLs. We found that changes in molecular speciation of CLs induced by exogenous C18-fatty acids (C18:1 and C18:2) in wild-type (wt) cells did not occur in any of the remodeling mutant cells, including cld1Δ, taz1Δ, and cld1Δtaz1Δ. Interestingly, molecular speciation of CLs in wt and double mutant cells cld1Δtaz1Δ was markedly different. Given that the bioenergetics functions are preserved in the double mutant, this suggests that the accumulated MLCL-rather than the changed CL speciation-are the likely major contributors to the mitochondrial dysfunction in taz1Δ mutant cells (also characteristic of Barth syndrome). Biochemical studies of Cld1 specificity and computer modeling confirmed the hydrolytic selectivity of the enzyme toward C16-CL substrates and the preservation of C18:1-containing CL species.

COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS

-

Page/Page column 310, (2017/07/18)

This disclosure provides improved lipid-based compositions, including lipid nanoparticle compositions, and methods of use thereof for delivering agents in vivo including nucleic acids and proteins. These compositions are not subject to accelerated blood clearance and they have an improved toxicity profile in vivo.

1,2-Diacrylglycerol and wherein the intermediate preparation method

-

Paragraph 0134-0135, (2017/01/23)

The invention discloses a preparation method for diacylglycero and an intermediate thereof. The preparation method for diacylglycero comprises the following steps: in an ether solvent and/or an alcohol solvent, in the present of an alkali, performing hydrolysis reaction on a compound shown as a formula 5, so as to obtain diacylglycero which is 1 shown in a formula 1. R in the formula 5 and 5 is C14-C18 saturated or unsaturated aliphatic acyl. The preparation method is cheap in raw materials, mild in reaction conditions, safe in operation, simple in postprocessing operation, high in reaction conversion rate, high in yield and suitable for large-scale production.

Synthesis of glycerol monostearate over K2CO3/γ-Al2O3 catalyst

Zhou, Lu,Gu, Yi,Hong, Mei,Xiao, Guomin

, p. 458 - 462 (2015/01/30)

The synthesis of glycerol monostearate by transesterification of methyl stearate with glycerol can be carried out in the presence of basic catalyst. The absence of solvent in the reaction system would result in a low conversion of methyl stearate as a consequence of low miscibility between reactants. The addition N,N′-dimethyl formamide as solvent improved the activity of the catalyst and selectivity to glycerol monostearate. Different K2CO3-containing γ-Al2O3 catalysts were made and used in the reaction. The results showed that catalyst with higher basicity could lead to better reactant's conversion but poorer selectivity to glycerol monostearate and the optimal load of K2CO3 inducing the highest yield to glycerol monostearate was 20 % mass fraction of γ-Al2O3 supporter. At a glycerol/methyl stearate ratio of 6:1, 165°C, 2 wt. % catalyst amount, a yield of 82.21 % of glycerol monostearate was achieved after 5h.

1-O-Alkyl (di)glycerol ethers synthesis from methyl esters and triglycerides by two pathways: Catalytic reductive alkylation and transesterification/reduction

Sutter, Marc,Dayoub, Wissam,Metay, Estelle,Raoul, Yann,Lemaire, Marc

supporting information, p. 786 - 797 (2013/04/24)

From available and bio-sourced methyl esters, monoglycerides or oleic sunflower refined oil, the corresponding 1-O-alkyl (di)glycerol ethers were obtained in both high yields and selectivity by two different pathways. With methyl esters, a reductive alkylation with (di)glycerol was realized under 50 bar hydrogen pressure in the presence of 1 mol% of Pd/C and an acid co-catalyst. A second two step procedure was evaluated from methyl esters or triolein and consisted of a first transesterification to the corresponding monoglyceride with a BaO/Al2O3 catalyst, then its reduction to the desired glycerol monoether with a recyclable heterogeneous catalytic system Pd/C and Amberlyst 35 under H2 pressure. In addition, a mechanism for the reaction was also proposed.

13C NMR quantification of mono and diacylglycerols obtained through the solvent-free lipase-catalyzed esterification of saturated fatty acids

Fernandes, Jane Luiza Nogueira,De Souza, Rodrigo Octavio Mendonca Alves,De Vasconcellos Azeredo, Rodrigo Bagueira

experimental part, p. 424 - 428 (2012/08/14)

In the present investigation, we studied the enzymatic synthesis of monoacylglycerols (MAG) and diacylglycerols (DAG) via the esterification of saturated fatty acids (stearic, palmitic and an industrial residue containing 87% palmitic acid) and glycerol in a solvent-free system. Three immobilized lipases (Lipozyme RM IM, Lipozyme TL IM and Novozym 435) and different reaction conditions were evaluated. Under the optimal reaction conditions, esterifications catalyzed by Lipozyme RM IM resulted in a mixture of MAG and DAG at high conversion rates for all of the substrates. In addition, except for the reaction of industrial residue at atmospheric pressure, all of these products met the World Health Organization and European Union directives for acylglycerol mixtures for use in food applications. The products were quantified by 13C NMR, with the aid of an external reference signal which was generated from a sealed coaxial tube filled with acetonitrile-d3. After calibrating the area of this signal using the classical external reference method, the same coaxial tube was used repeatedly to quantify the reaction products. Copyright

HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND MEHODS FOR MAKING AND USING THEM

-

Page/Page column 227; 18/138, (2008/06/13)

The invention provides hydrolases, polynucleotides encoding them, and methods of making and using these polynucleotides and polypeptides. In one aspect, the invention is directed to polypeptides, e.g., enzymes, having a hydrolase activity, e.g., an esterase, acylase, lipase, phospholipase (e.g., phosphlipase A, B, C and D acitvity, patatin activity, lipid acyl hydrolase (LAH) activity) or protease activity, including thermostable and thermotolerant hydrolase activity, and polynucleotides encoding these enzyme, and making and using these polynucleotides and polypeptides. The hydrolase activities of the polypeptides and peptides of the invention include esterase activity, lipase activity (hydrolysis of lipids), acidolysis reactions (to replace an esterified fatty acid with a free fatty acid), transesterification reactions (exchange of fatty acids between triglycerides), ester synthesis, ester interchange reactions, phospholipase activity and protease activity (hydrolysis of peptide bonds). The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural and industrial contexts, including the manufacture of cosmetics and nutraceuticals. In another aspect, the polypeptides of the invention are used to synthesize enantiomerically pure chiral products.

Design of well balanced hydrophilic-lipophilic catalytic surfaces for the direct and selective monoesterification of various polyols

Kharchafi, Ghizlane,Jerome, Francois,Adam, Isabelle,Pouilloux, Yannick,Barrault, Joel

, p. 928 - 934 (2007/10/03)

The transesterification process is a well known reaction of organic chemistry. However, the monoesterification of unprotected polyols such as glycerol or sucrose is much more complex and the design of selective catalysts is becoming a huge challenge in order to avoid many protection and deprotection steps, harmful for the cost and the environmental impact of the resulting process. In this study, we showed that the control of the hydrophilic-lipophilic balance of heterogeneous catalysts is a crucial key in order to tune both the catalyst activity and the monoester selectivity. Indeed, whereas homogeneous guanidine led to low selectivity toward monoesters, its anchorage on a hydrophilic solid support such as silica allowed us to prepare two basic hybrid organic-inorganic materials able to selectively afford monoesters in high yield and in an environmentally-friendly process, at low temperature and starting from an equimolecular mixture of unprotected polyols and various fatty methyl esters. The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2005.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51063-97-9